Profile
Mr. Ulf Thomas Blom is an Independent Director at Pharmiva AB, an EVP-Marketing & Innovation at Enzymatica AB and a Chief Executive Officer & Director at Medzyme Invest öresund AB. He is on the Board of Directors at Pharmiva AB, Medzyme Invest öresund AB, Enzymatica Care AB and Meminisse Process AB. Mr. Blom also served on the board at Idogen AB. He received his MBA from Lund University School of Economics & Management.
Ulf Thomas Blom active positions
| Companies | Position | Start |
|---|---|---|
| ENZYMATICA AB | Founder | 2006-12-31 |
| PHARMIVA AB (PUBL) | Director/Board Member | 2019-12-31 |
Enzymatica Care AB | Director/Board Member | - |
Medzyme Invest öresund AB | Chief Executive Officer | - |
Meminisse Process AB | Director/Board Member | - |
Former positions of Ulf Thomas Blom
| Companies | Position | End |
|---|---|---|
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Director/Board Member | - |
Training of Ulf Thomas Blom
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Enzymatica AB
Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Lund University School of Economics & Management
Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enzymatica Care AB | |
Medzyme Invest öresund AB | |
Pharmiva AB
Pharmiva AB Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
Meminisse Process AB |
- Stock Market
- Insiders
- Ulf Thomas Blom
















